NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)

NCT02819882

RecruitingN/A

Sponsor: Spanish Breast Cancer Research Group

Conditions: Breast Neoplasms

Interventions: No intervention

Countries: Spain

This study is a prospective, multicenter non-interventional cohort study designed to develop a registry in unresectable locally advanced or metastatic disease.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

1. Patients (males or females) diagnosed with unresectable locally advanced or MBC (either after a recurrence or as first diagnosis) from January 2016 onwards.
2. Patients who died are allowed to be included on the study.
3. Able and willing to provide written informed consent if they are alive.
4. Age ≥ 18 years.
5. Availability to medical records access and all data related to the disease management.

Exclusion Criteria:

None
Locations (40)
  • Elche, Alicante, Spain
  • Manresa, Barcelona, Spain
  • Terrassa, Barcelona, Spain
  • San Sebastián, Donostia, Spain
  • Las Palmas de Gran Canaria, Gran Canaria, Spain
  • Alcorcón, Madrid, Spain
  • Fuenlabrada, Madrid, Spain
  • Leganés, Madrid, Spain
  • San Sebastián de los Reyes, Madrid, Spain
  • Palma de Mallorca, Mallorca, Spain
  • Pamplona, Navarre, Spain
  • Santa Cruz de Tenerife, Tenerife, Spain
  • Sagunto, Valencia, Spain
  • Bilbao, Vizcaya, Spain
  • A Coruña, Spain
  • Albacete, Spain
  • Alicante, Spain
  • Ávila, Spain
  • Barcelona, Spain
  • Barcelona, Spain
  • Barcelona, Spain
  • Barcelona, Spain
  • Barcelona, Spain
  • Barcelona, Spain
  • Córdoba, Spain
  • León, Spain
  • Lugo, Spain
  • Madrid, Spain
  • Madrid, Spain
  • Málaga, Spain
  • + 10 more on CT.gov